Carson Seana, EVP and General Counsel at Bausch Health Companies (BHC), has demonstrated a consistent pattern of selling activity in the company’s stock, with no recorded purchases across 24 transactions totaling over $2.53 million in sales. The majority of these sales occurred in recent months, with eight transactions between late February and early March 2026, including a notable $820,635.90 disposition on March 2, 2026, classified under transaction code "J" (likely representing a gift or transfer). Other significant sales include a $377,326.95 transaction on September 5, 2025, and multiple six-figure dispositions earlier that year. The filings also show smaller but repeated sales, such as $25,503.40 and $39,627.68 on March 2–3, 2026, reinforcing a steady divestment trend.
Seana’s transactions are exclusively tied to BHC, with no activity in other companies. The filings include several "F" (tax liability) and "S" (open market sale) codes, suggesting routine stock-based compensation liquidations alongside discretionary sales. While some filings, marked "A" (award or grant), reflect equity awards with no immediate monetary value, the overall direction remains firmly skewed toward reducing exposure. The absence of any buy transactions over multiple years indicates a long-term disposition strategy rather than periodic rebalancing. The concentrated nature of these sales—all within a single company—highlights a clear and sustained reduction in Seana’s BHC holdings.
AI-assisted summary